Steroid-refractory pneumonitis

Clinical trials for Steroid-refractory pneumonitis explained in plain language.

Never miss a new study

Get alerted when new Steroid-refractory pneumonitis trials appear

Sign up with your email to follow new studies for Steroid-refractory pneumonitis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental lung inflammation treatment trial shuts down after just one patient

Disease control Stopped early

This phase 2 trial aimed to see if infliximab and intravenous immunoglobulin (IVIG) could help cancer patients with severe lung inflammation that didn't respond to steroids. Only one patient was enrolled before the study was terminated, so no meaningful results were obtained. The…

Matched conditions: STEROID-REFRACTORY PNEUMONITIS

Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

Steroid-refractory pneumonitis

Get alerted when new Steroid-refractory pneumonitis trials appear

Experimental lung inflammation treatment trial shuts down after just one patient